The importance of protecting the mechanical ventilator during colistin methanesulfonate nebulization

Intensive Care Medicine

Volumn 39, Issue 3, 2013, Pages 535-536

  Mojoli, Francesco ^a,b   Iotti, Giorgio Antonio ^b   Imberti, Roberto ^b   Braschi, Antonio ^a,b  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIMETHATE;

ACINETOBACTER BAUMANNII; CLINICAL EFFECTIVENESS; DRUG DELIVERY SYSTEM; FILTER; HUMAN; HUMIDIFIER; LETTER; MECHANICAL VENTILATOR; MEDICAL DEVICE COMPLICATION; NEBULIZATION; NEBULIZER; PATIENT SAFETY; PNEUMONIA; PRACTICE GUIDELINE;

ANTI-BACTERIAL AGENTS; BRONCHITIS; COLISTIN; DRUG RESISTANCE, MULTIPLE; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MALE; RESPIRATION, ARTIFICIAL; TRACHEITIS;

EID: 84884211840     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-012-2778-7     Document Type: Letter

References (3)

1. Athanassa ZE, Markantonis SL, Fousteri MZ, Myrianthefs PM, Boutzouka EG, Tsakris A, Baltopoulos GJ (2012) Pharmacokinetics of inhaled colistimethate sodium (CMS) in mechanically ventilated critically ill patients. Intensive Care Med 38(11):1779-1786
2. Ari A, Areabi H, Fink JB (2010) Evaluation of aerosol generator devices at 3 locations in humidified and non-humidified circuits during adult mechanical ventilation. Respir Care 55(7):837-844
3. Lu Q, Yang J, Liu Z, Gutierrez C, Aymard G, Rouby JJ (2011) Nebulized ceftazidime and amikacin in ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Am J Respir Crit Care Med 184(1):106-115